Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Flaherty

Showing results (121-130 of 204) with videos related to

Pageof 21
Sort By:
Scientific Reports|April 26, 2017
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processesDavid N O'Dwyer, Katy C Norman, Meng Xia, et al.
American Journal of Respiratory Cell and Molecular Biology|December 12, 2013
Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis modelLynne A Murray, Huilan Zhang, Sameer R Oak, et al.
The European Respiratory Journal|September 3, 2021
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trialKevin R Flaherty, Athol U Wells, Vincent Cottin, et al.
The European Respiratory Journal|April 23, 2015
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trialsHarold R Collard, Williamson Z Bradford, Vincent Cottin, et al.
BMC Pulmonary Medicine|March 16, 2020
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L Todd, Richard Vinisko, Yi Liu, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2016
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial PneumoniasEric S White, Meng Xia, Susan Murray, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2004
Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumoniaEsther S Choi, Claudia Jakubzick, Kristin J Carpenter, et al.
Scientific Reports|July 23, 2020
Identification of a unique temporal signature in blood and BAL associated with IPF progressionKaty C Norman, David N O'Dwyer, Margaret L Salisbury, et al.
The American Journal of Pathology|May 27, 2004
Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumoniaClaudia Jakubzick, Esther S Choi, Kristin J Carpenter, et al.
Chest|October 13, 2016
Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung DiseaseJamie S Sheth, John A Belperio, Michael C Fishbein, et al.
Pageof 21

Showing results (121-130 of 204) with videos related to

Sort By:
Pageof 21
Scientific Reports|April 26, 2017
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processesDavid N O'Dwyer, Katy C Norman, Meng Xia, et al.
American Journal of Respiratory Cell and Molecular Biology|December 12, 2013
Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis modelLynne A Murray, Huilan Zhang, Sameer R Oak, et al.
The European Respiratory Journal|September 3, 2021
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trialKevin R Flaherty, Athol U Wells, Vincent Cottin, et al.
The European Respiratory Journal|April 23, 2015
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trialsHarold R Collard, Williamson Z Bradford, Vincent Cottin, et al.
BMC Pulmonary Medicine|March 16, 2020
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L Todd, Richard Vinisko, Yi Liu, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2016
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial PneumoniasEric S White, Meng Xia, Susan Murray, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2004
Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumoniaEsther S Choi, Claudia Jakubzick, Kristin J Carpenter, et al.
Scientific Reports|July 23, 2020
Identification of a unique temporal signature in blood and BAL associated with IPF progressionKaty C Norman, David N O'Dwyer, Margaret L Salisbury, et al.
The American Journal of Pathology|May 27, 2004
Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumoniaClaudia Jakubzick, Esther S Choi, Kristin J Carpenter, et al.
Chest|October 13, 2016
Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung DiseaseJamie S Sheth, John A Belperio, Michael C Fishbein, et al.
Pageof 21